Biotech

All Articles

BMS trenches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is axing an additional huge wager coming from the Caforio time, ending a barga...

Nuvation halts BET prevention after considering phase 1 data

.After checking out at period 1 information, Nuvation Bio has actually chosen to halt work on its on...

' Scientific instinct' led FDA advisors to support Zevra's rare health condition med

.Zevra Therapies' uncommon condition medication seems to be on the road to authorization this fall a...

Pfizer takes $230M attacked after axing failed DMD genetics treatment

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has blown a $230 mi...

AC Immune views 'spots' prospective in Alzheimer's medicine data

.After greater than 20 years of work on neurodegenerative ailments, Swiss biotech air conditioning I...

GSK goes down ph. 2 HPV vaccination over absence of best-in-class potential

.GSK has junked a phase 2 human papillomavirus (HPV) injection from its pipeline after choosing the ...

OS Treatments refiles $6M IPO to fund HER2 drug, preclinical ADCs

.Operating system Therapies will note on the NYSE American stock swap today by means of a $6.4 thous...

ALX's waning CD47 reaction cost sends out stock spiraling down

.ALX Oncology's phase 2 stomach cancer cells reaction rate has actually damaged. After seeing its ow...

Ionis centers eye ailment coming from aim ats of Roche-partnered prospect after records let down

.Another of Ionis Pharmaceuticals' vital midphase readouts has actually fallen short of requirements...

Biogen's CEO said no dangerous deals in 2023. He prepares to become strong

.While Biogen's pharma peers are actually searching for late-stage properties along with little bit ...